Drug Safety & Clinical Trial Intelligence
Instantly analyze side effects profiles and current trial pipelines for over 50,000+ compounds.
Metformin
FDA Approved Substance • Biguanide Class
Safety Summary
Seriousness Breakdown
Top Reported Adverse Reactions
Gender Demographics
Unlock demographic data with the Investor Catalyst Plan
Gender Distribution
Age Cohort Distributions
Unlock age distributions with the Investor Catalyst Plan
Adverse Event Count by Patient Age Group
Risk Assessment
Risk assessment is derived from historical seriousness ratios registered in FDA FAERS database.
| NCT ID | Trial Title | Phase | Sponsor | Status |
|---|
Show 50+ More Clinical Trials
Unlock the complete clinical trials list and phase filters with Investor Catalyst.
Comparative Intelligence Suite
Unlock automatic side-effect to trial exclusion criteria cross-referencing algorithms with Pro.
Safety Overlaps & Clinical Risk Correlation
This panel evaluates whether current active clinical trials include criteria or protocols that target or exclude patients experiencing the top adverse reactions identified in general usage.
Side-Effect to Trial Match
Trials filtering patients specifically based on reactions found in openFDA reports.
Active Trial Interventions Mapping
Breakdown of trial categories (interventional, observational, etc.) for this drug.
PubMed Safety Literature
Recent peer-reviewed safety & toxicology publications from NCBI.
Executive Summary Dossier Generator
Generate, customize, and save drug safety and catalyst briefing profiles as PDF dossiers.
Executive Summary Dossier Briefing
Generate a print-ready briefing document summarizing safety profiles and clinical trial stages for this drug.
Querying FDA databases and clinical registries...